Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? (Q94588786)

From Wikidata
Jump to navigation Jump to search
scientific article published on 05 May 2020
edit
Language Label Description Also known as
English
Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?
scientific article published on 05 May 2020

    Statements

    Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit